ALBANY, N.Y.--(BUSINESS WIRE)-- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the Stephens Inc.Fall Investment Conference at 1:30 p.m. ET on Wednesday, November 17, 2010, at The New York Palace Hotel. Joseph Gersuk, Executive Vice President and Chief Financial Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.

Attendance at the conference is by invitation only. Individuals can view an archived webcast and slide presentation on the Internet by visiting the investor relations portion of the Company's Web site at: http://investors.angiodynamics.com. The archived presentation will be available for 90 days.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics' diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Greg Gin, 415-896-6820 (Investor Relations)
ggin@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com

Source: AngioDynamics, Inc.

News Provided by Acquire Media